Advertisement

Spinal Tech

Advertisement

Amedica, a biomaterial company focused on using its silicon nitride technology platform to develop a range of medical devices, announced that it will cease distribution of amniotic derived allograft products under a distribution agreement with a third party supplier.

Advertisement